Revisiting biochemistry: severe euglycemic ketoacidosis in the setting of IDH-inhibitor therapy for AML. Khan M, Roddy JT, Hernandez JR, Bursch K, et al. Br J Haematol 2021;194:1083-1085.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Khan M, Roddy JT, Hernandez JR, Bursch K, et al. Revisiting biochemistry: severe euglycemic ketoacidosis in the setting of IDH-inhibitor therapy for AML. Br J Haematol 2021;194:1083-1085.
PMID: 34101165